Trion Pharma GmbH

https://www.trionpharma.com

TRION Pharma GmbH is a biopharmaceutical company developing trifunctional antibodies (Triomab®). The trifunctional antibodies are produced at TRION's site in Munich, Germany , and are based on a proprietary platform technology for which TRION has secured IP rights around the world. *

	Start	1998-03-01 established
	End	2013-10-10 bankruptcy filed
	Today	Lindis Biotech GmbH
	Industry	catumaxomab
	Person	Lindhofer, Horst (Lindis Pharma 201004– CEO + Founder before Trion Pharma CEO + Founder)

	Region	München (Munich)
	Country	Germany
	Street	193A Frankfurter Ring
	City	80807 München
	Tel	+49-89-324266-0
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2025-03-16

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)